Short Interest in CanSino Biologics Inc. (OTCMKTS:CASBF) Increases By 10.6%

CanSino Biologics Inc. (OTCMKTS:CASBF) saw a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 1,275,200 shares, a growth of 10.6% from the March 31st total of 1,153,400 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is currently 12,752.0 days.

CanSino Biologics Stock Performance

CASBF stock opened at C$2.10 on Tuesday. CanSino Biologics has a twelve month low of C$1.86 and a twelve month high of C$5.41. The business’s fifty day simple moving average is C$2.07 and its two-hundred day simple moving average is C$2.57.

CanSino Biologics Company Profile

CanSino Biologics Inc develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N.